Clinical trials
Hodgkin Disease trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Rigshospitalet, Denmark | 2 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| German Hodgkin's Lymphoma Study Group | 1 |
| GlaxoSmithKline | 1 |
| Hutchmed | 1 |
| Marjolein Spiering | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 17 |
| Lymphoma | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Multiple Myeloma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Waldenstrom Macroglobulinemia | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.